insights_auto
Warum stieg BT3 um 2,14%?
Mehr erfahrenchevron_right
BT3:FRA
BioTime
0,76 €
arrow_upward
+2,14%(+0,016) 1 T
20. Nov., 22:00:00 GMT+1 · EUR
search
Alle Symbole
| Symbol | Kurs | Änderung | Änderung in % |
|---|
insights_autoWichtige Einblicke für BT3 werden generiert…
Öffnen
0,76 €
Höchstwert
0,76 €
Tiefstwert
0,76 €
Börsenwert
195,26 Mio.
Durchschn. HVol.
100,00
Handelsvolumen
0,00
52-Wochen-Hoch
1,68 €
52-Wochen-Tief
0,72 €
Anzahl der Mitarbeiter
75
Öffnen
0,76 €
Höchstwert
0,76 €
Tiefstwert
0,76 €
Börsenwert
195,26 Mio.
Durchschn. HVol.
100,00
Handelsvolumen
0,00
52-Wochen-Hoch
1,68 €
52-Wochen-Tief
0,72 €
Anzahl der Mitarbeiter
75
Nachrichtenmeldungen
Aus Webquellen und von Nachrichtenpartnern
Investing.com
·
vor 2 Tagen
Broadwood Partners, L.P. buys $770,700 in Lineage Cell Therapeutics stock
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Über BioTime